Outcomes | Non-cryopreserved(n=26) | Cryopreserved(n=16) | P value |
---|---|---|---|
Time to neutrophil engraftment (days) -- median (range) | 12 (10-19) | 10.5 (8-20) | 0.203 |
Time to platelet engraftment (days) -- median (range) | 14 (10-23) | 12 (10-31) | 0.809 |
Incidence of graft failure -- no. (%) | 0 | 0 | 1.000 |
Transplant-related mortality -- no. (%) | 1 (3.8) | 0 | 0.619 |
CD34+ cell dose (x106 cells/kg) -- median (range) | 3.8 (2.0-16.5) | 4.7 (2.3-29.1) | 0.062 |
CD34+ cell viability (%) -- median (range) | 98.5 (94-99) | 93.5 (70-98) | <0.001 |
Stem cells infusion reactions -- no. (%) | 5 (19.2) | 6 (37.5) | 0.172 |
Total days of hospitalization -- median (range) | 25.5 (18-30) | 33 (17-55) | 0.002 |
Total cost of ASCT (in 1,000 THB) -- mean ± SD | 340.5 ± 75.8 | 377.7 ± 159.8 | 0.394 |